GERON CORP Share-based Payment Arrangement, Amount Capitalized
GERON CORP (GERN) reported Share-based Payment Arrangement, Amount Capitalized of $1.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Expensed and Capitalized, Amount
us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount · last filed 2026-03-02
- GERON CORP share-based payment arrangement, amount capitalized for the quarter ending 2025-12-31 was $300.00K, a 0.00% change year-over-year.
- GERON CORP share-based payment arrangement, amount capitalized for the quarter ending 2025-09-30 was $300.00K, a 0.00% change year-over-year.
- GERON CORP share-based payment arrangement, amount capitalized for the quarter ending 2025-06-30 was $300.00K, a 200.00% increase year-over-year.
- GERON CORP share-based payment arrangement, amount capitalized for the quarter ending 2025-03-31 was $300.00K.
- GERON CORP share-based payment arrangement, amount capitalized for fiscal 2025 was $1.30M, a 85.71% increase from fiscal 2024.
- GERON CORP share-based payment arrangement, amount capitalized for fiscal 2024 was $700.00K.
- GERON CORP share-based payment arrangement, amount capitalized for fiscal 2023 was $0.00.
| Period end | Share-based Payment Arrangement, Amount Capitalized 3 month | Share-based Payment Arrangement, Amount Capitalized 6 month | Share-based Payment Arrangement, Amount Capitalized 9 month | Share-based Payment Arrangement, Amount Capitalized 12 month |
|---|---|---|---|---|
| 2025-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $600.00K derived: sum of 2 quarters · filed 2026-03-02 | $900.00K derived: sum of 3 quarters · filed 2026-03-02 | $1.30M 10-K · filed 2026-03-02 |
| 2025-09-30 | $300.00K 10-Q · filed 2025-11-07 | $600.00K derived: sum of 2 quarters · filed 2025-11-07 | $1.00M 10-Q · filed 2025-11-07 | $1.20M derived: sum of 4 quarters · filed 2026-03-02 |
| 2025-06-30 | $300.00K 10-Q · filed 2025-08-06 | $600.00K 10-Q · filed 2025-08-06 | $900.00K derived: sum of 3 quarters · filed 2026-03-02 | $1.20M derived: sum of 4 quarters · filed 2026-03-02 |
| 2025-03-31 | $300.00K 10-Q · filed 2025-05-07 | $600.00K derived: sum of 2 quarters · filed 2026-03-02 | $900.00K derived: sum of 3 quarters · filed 2026-03-02 | $1.00M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $600.00K derived: sum of 2 quarters · filed 2026-03-02 | $700.00K derived: sum of 3 quarters · filed 2026-03-02 | $700.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $300.00K 10-Q · filed 2025-11-07 | $400.00K derived: sum of 2 quarters · filed 2025-11-07 | $400.00K 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $100.00K 10-Q · filed 2025-08-06 | $100.00K 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |